• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 COPD 加重频率变化相关的因素。

Factors associated with change in exacerbation frequency in COPD.

机构信息

Centre for Respiratory Medicine, UCL Medical School, Royal Free Campus, Rowland Hill Street Hampstead, London NW3 2PF, UK.

出版信息

Respir Res. 2013 Jul 30;14(1):79. doi: 10.1186/1465-9921-14-79.

DOI:10.1186/1465-9921-14-79
PMID:23899210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3733814/
Abstract

BACKGROUND

Patients with chronic obstructive pulmonary disease (COPD) can be categorized as having frequent (FE) or infrequent (IE) exacerbations depending on whether they respectively experience two or more, or one or zero exacerbations per year. Although most patients do not change category from year to year, some will, and the factors associated with this behaviour have not been examined.

METHODS

1832 patients completing two year follow-up in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) study were examined at baseline and then yearly. Exacerbations were defined by health care utilisation. Patient characteristics compared between those patients who did or did not change exacerbation category from year 1 to year 2.

FINDINGS

Between years 1 and 2, 221 patients (17%) changed from IE to FE and 210 patients (39%) from FE to IE. More severe disease was associated with changing from IE to FE and less severe disease from FE to IE. Over the preceding year, small falls in FEV1 and 6-minute walking distance were associated with changing from IE to FE, and small falls in platelet count associated with changing from FE to IE.

CONCLUSION

No parameter clearly predicts an imminent change in exacerbation frequency category.

TRIAL REGISTRATION

SCO104960, clinicaltrials.gov identifier NCT00292552.

摘要

背景

根据患者每年经历 2 次或以上或 1 次或 0 次加重的情况,可将慢性阻塞性肺疾病(COPD)患者分为频繁加重(FE)或不频繁加重(IE)。尽管大多数患者每年不会改变分类,但有些患者会,而与这种行为相关的因素尚未被研究。

方法

在评估 COPD 患者纵向以确定预测替代终点(ECLIPSE)研究中,1832 例完成 2 年随访的患者在基线时以及每年接受检查。加重通过医疗保健利用来定义。在第 1 年至第 2 年期间,比较患者的特征,这些患者的加重类别从第 1 年到第 2 年发生了变化或没有变化。

结果

在第 1 年至第 2 年之间,221 例(17%)患者从 IE 转为 FE,210 例(39%)患者从 FE 转为 IE。更严重的疾病与从 IE 转为 FE 有关,而从 FE 转为 IE 则与更严重的疾病有关。在前一年,FEV1 和 6 分钟步行距离的轻微下降与从 IE 转为 FE 有关,血小板计数的轻微下降与从 FE 转为 IE 有关。

结论

没有明确的参数可以预测加重频率类别的变化。

注册号

SCO104960,临床试验标识符 NCT00292552。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/539f/3733814/414d467370a3/1465-9921-14-79-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/539f/3733814/88c0d4fdcf26/1465-9921-14-79-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/539f/3733814/414d467370a3/1465-9921-14-79-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/539f/3733814/88c0d4fdcf26/1465-9921-14-79-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/539f/3733814/414d467370a3/1465-9921-14-79-2.jpg

相似文献

1
Factors associated with change in exacerbation frequency in COPD.与 COPD 加重频率变化相关的因素。
Respir Res. 2013 Jul 30;14(1):79. doi: 10.1186/1465-9921-14-79.
2
No association between exacerbation frequency and stroke in patients with COPD.慢性阻塞性肺疾病(COPD)患者的急性加重频率与中风之间无关联。
Int J Chron Obstruct Pulmon Dis. 2016 Feb 2;11:217-25. doi: 10.2147/COPD.S95775. eCollection 2016.
3
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.慢性阻塞性肺疾病患者的加重频率:SPIROMICS 队列分析。
Lancet Respir Med. 2017 Aug;5(8):619-626. doi: 10.1016/S2213-2600(17)30207-2. Epub 2017 Jun 28.
4
Susceptibility to exacerbation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病恶化的易感性。
N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883.
5
Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.探讨年龄对慢性阻塞性肺疾病健康结局的影响:来自慢性阻塞性肺疾病遗传流行病学研究和评估慢性阻塞性肺疾病纵向以确定预测替代终点队列的结果。
J Am Med Dir Assoc. 2017 Dec 1;18(12):1063-1068. doi: 10.1016/j.jamda.2017.09.028.
6
Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?频繁的中度加重是否会导致戒烟者慢性阻塞性肺疾病的进展?
Int J Chron Obstruct Pulmon Dis. 2015 Mar 10;10:525-33. doi: 10.2147/COPD.S76475. eCollection 2015.
7
Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations.慢性阻塞性肺疾病患者中频繁和不频繁加重者的呼吸困难感知不同。
Thorax. 2017 Feb;72(2):117-121. doi: 10.1136/thoraxjnl-2016-208332. Epub 2016 Sep 1.
8
Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease.体力活动与慢性阻塞性肺疾病患者急性加重频率的关系。
Lung. 2015 Feb;193(1):63-70. doi: 10.1007/s00408-014-9673-7. Epub 2014 Dec 13.
9
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study.急性慢阻肺加重预测工具(ACCEPT):一项建模研究。
Lancet Respir Med. 2020 Oct;8(10):1013-1021. doi: 10.1016/S2213-2600(19)30397-2. Epub 2020 Mar 13.
10
The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.抑郁症状与 COPD 患者急性加重率的相关性:ECLIPSE 队列 3 年纵向随访研究结果。
J Am Med Dir Assoc. 2017 Nov 1;18(11):955-959.e6. doi: 10.1016/j.jamda.2017.05.024. Epub 2017 Jul 18.

引用本文的文献

1
A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.一项关于长期多西环素治疗对稳定期慢性阻塞性肺疾病患者加重率影响的双盲、随机、安慰剂对照试验。
Am J Respir Crit Care Med. 2023 Sep 1;208(5):549-558. doi: 10.1164/rccm.202212-2287OC.
2
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review.轻度或轻度至中度慢性阻塞性肺疾病患者的疾病负担(全球慢性阻塞性肺疾病倡议组 A 或 B):系统文献回顾。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 29;18:719-731. doi: 10.2147/COPD.S394325. eCollection 2023.
3

本文引用的文献

1
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 执行摘要。
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9.
2
Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities.血小板在健康和疾病中的功能:从分子机制、氧化还原考虑到新的治疗机会。
Antioxid Redox Signal. 2012 Nov 15;17(10):1447-85. doi: 10.1089/ars.2011.4324. Epub 2012 May 8.
3
COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.
Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk.慢性阻塞性肺疾病严重加重的轨迹及其与死亡风险的关系。
Lung. 2022 Oct;200(5):601-607. doi: 10.1007/s00408-022-00565-8. Epub 2022 Sep 5.
4
Towards precision in defining COPD exacerbations.迈向慢性阻塞性肺疾病加重定义的精准化。
Breathe (Sheff). 2021 Sep;17(3):210081. doi: 10.1183/20734735.0081-2021.
5
COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort.COPD 临床控制:CHAIN 队列的预测因素和长期随访。
Respir Res. 2021 Feb 4;22(1):36. doi: 10.1186/s12931-021-01633-y.
6
Findings from a pilot randomised trial of a social network self-management intervention in COPD.一项 COPD 社会网络自我管理干预的初步随机试验结果。
BMC Pulm Med. 2020 Jun 8;20(1):162. doi: 10.1186/s12890-020-1130-1.
7
Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.COPD 合并症患者的管理:专家建议文件。
Int J Chron Obstruct Pulmon Dis. 2020 May 7;15:1015-1037. doi: 10.2147/COPD.S242009. eCollection 2020.
8
Identification of Patient Profiles with High Risk of Hospital Re-Admissions for Acute COPD Exacerbations (AECOPD) in France Using a Machine Learning Model.利用机器学习模型在法国识别急性 COPD 加重(AECOPD)再入院风险较高的患者特征。
Int J Chron Obstruct Pulmon Dis. 2020 Apr 30;15:949-962. doi: 10.2147/COPD.S236787. eCollection 2020.
9
Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach.采用新型基于加重期的马尔可夫模型评估茚达特罗/格隆溴铵与沙美特罗/氟替卡松的成本-效果
Int J Chron Obstruct Pulmon Dis. 2020 Apr 16;15:787-797. doi: 10.2147/COPD.S247156. eCollection 2020.
10
Genetic variants in IL17A and serum levels of IL-17A are associated with COPD related to tobacco smoking and biomass burning.IL17A 中的遗传变异和血清中 IL-17A 的水平与与吸烟和生物质燃烧有关的 COPD 相关。
Sci Rep. 2020 Jan 21;10(1):784. doi: 10.1038/s41598-020-57606-6.
COPD 相关性及 ECLIPSE 队列中血液生物标志物的可重复性。
Respir Res. 2011 Nov 4;12(1):146. doi: 10.1186/1465-9921-12-146.
4
Changes in forced expiratory volume in 1 second over time in COPD.COPD 患者 1 秒用力呼气容积随时间的变化。
N Engl J Med. 2011 Sep 29;365(13):1184-92. doi: 10.1056/NEJMoa1105482. Epub 2011 Sep 26.
5
Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.他汀类药物在慢性阻塞性肺疾病患者中的使用与住院治疗:台湾一项基于全国人群的队列研究。
Clin Ther. 2011 Oct;33(10):1365-70. doi: 10.1016/j.clinthera.2011.08.010. Epub 2011 Oct 2.
6
Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke.他汀类药物预处理与急性非心源性缺血性脑卒中患者的血小板活性降低和预后改善相关。
Crit Care. 2011 Jul 8;15(4):R163. doi: 10.1186/cc10303.
7
Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease.血小板计数、平均血小板体积与稳定期慢性阻塞性肺疾病患者的吸烟状况。
Platelets. 2011;22(6):466-70. doi: 10.3109/09537104.2011.573887. Epub 2011 Apr 20.
8
Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort.定量肺气肿程度:利用 ECLIPSE 队列评估放射科医生的估计值和肺气肿严重程度的定量指标的相关因素。
Acad Radiol. 2011 Jun;18(6):661-71. doi: 10.1016/j.acra.2011.01.011. Epub 2011 Mar 9.
9
Association between lung function and exacerbation frequency in patients with COPD.COPD 患者肺功能与加重频率的相关性。
Int J Chron Obstruct Pulmon Dis. 2010 Dec 9;5:435-44. doi: 10.2147/COPD.S13826.
10
Reproducibility of 6-minute walking test in patients with COPD.COPD 患者 6 分钟步行试验的可重复性。
Eur Respir J. 2011 Aug;38(2):261-7. doi: 10.1183/09031936.00142010. Epub 2010 Dec 22.